Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I love all the blanket statments on this board....

I love all the blanket statments on this board....

posted on Sep 14, 2008 11:12AM

In PTSC past the steady rise in OS shares has been a problem... But the approx 30 million increase should be seen as ... the cost of the shares and cash what type of return did get for what we paid... 10 million..(which I know may have cost PTSC more then 10 million becuase of the cost of the shares..)... we will need to wait & see what type of return & what type of synergy we gain from the purchase of crossflo.... We know Crossflo had 20 million in sales.. if we see 5 million in profits... we get a return on our money In two years... You must remember when we purchased Crossflo they may have also felt we are undervalued and requested mostly shares... I am more interested on what we see moving forward... I assume with crossflo we will also gain cost advantegs... maybe remove operation cost.... Once again each deal should be looked for cost & return not how many OS share it cost!!!!... We need to see steady earning first then growing steady earning next!!!



GLALL

Share
New Message
Please login to post a reply